| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | procollagen-proline 3-dioxygenase activity | 5.09e-08 | 3 | 75 | 3 | GO:0019797 | |
| GeneOntologyMolecularFunction | peptidyl-proline 3-dioxygenase activity | 2.03e-07 | 4 | 75 | 3 | GO:0031544 | |
| GeneOntologyMolecularFunction | procollagen-proline dioxygenase activity | 2.81e-06 | 8 | 75 | 3 | GO:0019798 | |
| GeneOntologyMolecularFunction | peptidyl-proline dioxygenase activity | 1.09e-05 | 12 | 75 | 3 | GO:0031543 | |
| GeneOntologyMolecularFunction | L-ascorbic acid binding | 5.54e-05 | 20 | 75 | 3 | GO:0031418 | |
| GeneOntologyMolecularFunction | vitamin binding | 3.51e-04 | 161 | 75 | 5 | GO:0019842 | |
| GeneOntologyCellularComponent | Mon1-Ccz1 complex | 1.23e-04 | 5 | 74 | 2 | GO:0035658 | |
| Domain | 2OG-FeII_Oxy_3 | 1.00e-05 | 11 | 75 | 3 | PF13640 | |
| Domain | DUF1712 | 1.59e-05 | 2 | 75 | 2 | PF08217 | |
| Domain | Atrophin-like | 1.59e-05 | 2 | 75 | 2 | IPR002951 | |
| Domain | DUF1712_fun | 1.59e-05 | 2 | 75 | 2 | IPR013176 | |
| Domain | Atrophin-1 | 1.59e-05 | 2 | 75 | 2 | PF03154 | |
| Domain | P4Hc | 3.35e-05 | 16 | 75 | 3 | SM00702 | |
| Domain | Pro_4_hyd_alph | 3.35e-05 | 16 | 75 | 3 | IPR006620 | |
| Domain | 2OG-FeII_Oxy | 5.75e-05 | 19 | 75 | 3 | PF03171 | |
| Domain | FE2OG_OXY | 7.85e-05 | 21 | 75 | 3 | PS51471 | |
| Domain | NEBU | 9.50e-05 | 4 | 75 | 2 | SM00227 | |
| Domain | Nebulin | 9.50e-05 | 4 | 75 | 2 | PF00880 | |
| Domain | Nebulin | 9.50e-05 | 4 | 75 | 2 | IPR013998 | |
| Domain | NEBULIN | 9.50e-05 | 4 | 75 | 2 | PS51216 | |
| Domain | Nebulin_repeat | 9.50e-05 | 4 | 75 | 2 | IPR000900 | |
| Domain | Oxoglu/Fe-dep_dioxygenase | 1.04e-04 | 23 | 75 | 3 | IPR005123 | |
| Domain | Na_trans_cytopl | 2.36e-04 | 6 | 75 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 2.36e-04 | 6 | 75 | 2 | IPR024583 | |
| Domain | Na_channel_asu | 7.01e-04 | 10 | 75 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 7.01e-04 | 10 | 75 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 7.01e-04 | 10 | 75 | 2 | PF06512 | |
| Domain | ER_TARGET | 8.88e-04 | 47 | 75 | 3 | PS00014 | |
| Domain | Thioredoxin | 1.21e-03 | 13 | 75 | 2 | IPR005746 | |
| Domain | RabGAP-TBC | 1.26e-03 | 53 | 75 | 3 | PF00566 | |
| Domain | zf-H2C2_2 | 1.40e-03 | 14 | 75 | 2 | PF13465 | |
| Domain | TBC_RABGAP | 1.40e-03 | 55 | 75 | 3 | PS50086 | |
| Domain | Rab-GTPase-TBC_dom | 1.40e-03 | 55 | 75 | 3 | IPR000195 | |
| Domain | Pentatricopeptide_repeat | 3.81e-03 | 23 | 75 | 2 | IPR002885 | |
| Domain | THIOREDOXIN_1 | 4.50e-03 | 25 | 75 | 2 | PS00194 | |
| Pubmed | Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes. | 1.04e-08 | 3 | 77 | 3 | 15044469 | |
| Pubmed | Expression of prolyl 3-hydroxylase genes in embryonic and adult mouse tissues. | 1.04e-08 | 3 | 77 | 3 | 19652424 | |
| Pubmed | Conservation of notochord gene expression across chordates: insights from the Leprecan gene family. | 3.73e-06 | 14 | 77 | 3 | 18798549 | |
| Pubmed | Distinct behavioral and neuropathological abnormalities in transgenic mouse models of HD and DRPLA. | 4.84e-06 | 2 | 77 | 2 | 11442350 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 10814707 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 28555636 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18487197 | ||
| Pubmed | The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer. | 4.84e-06 | 2 | 77 | 2 | 19436308 | |
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 4.84e-06 | 2 | 77 | 2 | 27174182 | |
| Pubmed | LEPREL1, a novel ER and Golgi resident member of the Leprecan family. | 4.84e-06 | 2 | 77 | 2 | 15063763 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 32160108 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 10702271 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 19131340 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 15302875 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 11807410 | ||
| Pubmed | Simultaneous activation of JAK1 and JAK2 confers IL-3 independent growth on Ba/F3 pro-B cells. | 2.89e-05 | 4 | 77 | 2 | 15988755 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 18651325 | ||
| Pubmed | A translational silencing function of MCPIP1/Regnase-1 specified by the target site context. | 2.89e-05 | 4 | 77 | 2 | 29471506 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 17150957 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 20305638 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 4.81e-05 | 588 | 77 | 8 | 38580884 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 8812438 | ||
| Pubmed | Endosomal WASH and exocyst complexes control exocytosis of MT1-MMP at invadopodia. | 4.82e-05 | 5 | 77 | 2 | 24344185 | |
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 4.82e-05 | 5 | 77 | 2 | 22875929 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 38918046 | ||
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 16029194 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 7.22e-05 | 6 | 77 | 2 | 23652591 | |
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 28445460 | ||
| Pubmed | Dysregulation of NRAP degradation by KLHL41 contributes to pathophysiology in nemaline myopathy. | 7.22e-05 | 6 | 77 | 2 | 30986853 | |
| Pubmed | 8.31e-05 | 103 | 77 | 4 | 11752456 | ||
| Pubmed | CASP8AP2 ZNF131 AIFM2 MCMBP BCAP31 ERAP2 P3H1 FASTKD2 TMX3 ADGRL2 CDC42BPB HERC5 | 1.00e-04 | 1487 | 77 | 12 | 33957083 | |
| Pubmed | Histone deacetylase-associating Atrophin proteins are nuclear receptor corepressors. | 1.01e-04 | 7 | 77 | 2 | 16481466 | |
| Pubmed | Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity. | 1.01e-04 | 7 | 77 | 2 | 22510986 | |
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 15128873 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 11121205 | ||
| Pubmed | 1.34e-04 | 8 | 77 | 2 | 25282160 | ||
| Pubmed | 1.34e-04 | 8 | 77 | 2 | 19933700 | ||
| Pubmed | 1.34e-04 | 8 | 77 | 2 | 20886612 | ||
| Pubmed | 1.72e-04 | 9 | 77 | 2 | 16382098 | ||
| Pubmed | 1.72e-04 | 9 | 77 | 2 | 9535906 | ||
| Pubmed | 1.74e-04 | 529 | 77 | 7 | 14621295 | ||
| Pubmed | 3.15e-04 | 12 | 77 | 2 | 22315970 | ||
| Pubmed | 3.71e-04 | 13 | 77 | 2 | 15123669 | ||
| Pubmed | A gene-rich cluster between the CD4 and triosephosphate isomerase genes at human chromosome 12p13. | 4.33e-04 | 14 | 77 | 2 | 8723724 | |
| Pubmed | 5.13e-04 | 1049 | 77 | 9 | 27880917 | ||
| Pubmed | JAK1 EEF2 SNRNP48 SORBS2 NFKBID EXOC1 PC CDC42BPB PREX1 XAB2 | 5.30e-04 | 1285 | 77 | 10 | 35914814 | |
| Pubmed | KLHL40 deficiency destabilizes thin filament proteins and promotes nemaline myopathy. | 5.69e-04 | 16 | 77 | 2 | 24960163 | |
| Pubmed | 5.69e-04 | 16 | 77 | 2 | 21343368 | ||
| Pubmed | 5.69e-04 | 16 | 77 | 2 | 9445485 | ||
| Pubmed | 5.69e-04 | 16 | 77 | 2 | 26527618 | ||
| Pubmed | Bmp7 drives proximal tubule expansion and determines nephron number in the developing kidney. | 5.69e-04 | 16 | 77 | 2 | 35877077 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 6.37e-04 | 861 | 77 | 8 | 36931259 | |
| Pubmed | Genome-wide analysis of the p53 gene regulatory network in the developing mouse kidney. | 6.44e-04 | 17 | 77 | 2 | 24003036 | |
| Pubmed | Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways. | 6.44e-04 | 17 | 77 | 2 | 12960231 | |
| Pubmed | Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages. | 6.44e-04 | 17 | 77 | 2 | 18453587 | |
| Pubmed | 6.44e-04 | 17 | 77 | 2 | 14741744 | ||
| Pubmed | 7.23e-04 | 18 | 77 | 2 | 14645126 | ||
| Pubmed | 8.07e-04 | 19 | 77 | 2 | 24073214 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 8.15e-04 | 495 | 77 | 6 | 27705803 | |
| Pubmed | 8.96e-04 | 20 | 77 | 2 | 15967462 | ||
| Pubmed | 8.96e-04 | 20 | 77 | 2 | 9074930 | ||
| Pubmed | Human immunodeficiency virus type 1 Vpr: functions and molecular interactions. | 8.96e-04 | 20 | 77 | 2 | 19458171 | |
| Pubmed | An Alternative Splicing Program for Mouse Craniofacial Development. | 9.89e-04 | 21 | 77 | 2 | 33013468 | |
| Pubmed | Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. | 1.10e-03 | 91 | 77 | 3 | 21833088 | |
| Pubmed | 1.14e-03 | 92 | 77 | 3 | 20301317 | ||
| Pubmed | 1.19e-03 | 23 | 77 | 2 | 26002199 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.23e-03 | 954 | 77 | 8 | 36373674 | |
| Pubmed | 1.24e-03 | 360 | 77 | 5 | 33111431 | ||
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 1.28e-03 | 212 | 77 | 4 | 33462405 | |
| Pubmed | 1.29e-03 | 24 | 77 | 2 | 23360989 | ||
| Pubmed | Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney. | 1.29e-03 | 24 | 77 | 2 | 17036046 | |
| Pubmed | 1.49e-03 | 101 | 77 | 3 | 9872452 | ||
| Pubmed | 1.53e-03 | 560 | 77 | 6 | 35241646 | ||
| Pubmed | 1.54e-03 | 378 | 77 | 5 | 34315543 | ||
| Pubmed | 1.64e-03 | 27 | 77 | 2 | 19026994 | ||
| Pubmed | 1.72e-03 | 1006 | 77 | 8 | 15226823 | ||
| Pubmed | 1.76e-03 | 107 | 77 | 3 | 11347906 | ||
| Pubmed | 1.76e-03 | 28 | 77 | 2 | 17698011 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 1.83e-03 | 1016 | 77 | 8 | 19056867 | |
| Pubmed | 1.84e-03 | 234 | 77 | 4 | 36243803 | ||
| Pubmed | 1.89e-03 | 29 | 77 | 2 | 26959361 | ||
| Pubmed | 1.89e-03 | 29 | 77 | 2 | 39289460 | ||
| Pubmed | 1.99e-03 | 239 | 77 | 4 | 23246001 | ||
| Pubmed | 2.02e-03 | 30 | 77 | 2 | 29137925 | ||
| Pubmed | 2.12e-03 | 407 | 77 | 5 | 15772651 | ||
| Cytoband | Xq26.1 | 3.28e-04 | 16 | 77 | 2 | Xq26.1 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.70e-04 | 9 | 40 | 2 | 1203 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.40e-07 | 166 | 77 | 6 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 1.06e-05 | 167 | 77 | 5 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.09e-05 | 168 | 77 | 5 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 170 | 77 | 5 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 170 | 77 | 5 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-05 | 183 | 77 | 5 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 197 | 77 | 5 | 1eb9ff8467118b943b5d443cb996168e1e1206b5 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 101 | 77 | 4 | 6c4524be89cf3eb06769c2963dcded3da1e71ca0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.85e-05 | 135 | 77 | 4 | 88f86bab637f1ca1439c7de2d12be4329cf662b8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 140 | 77 | 4 | 5e81fa3a19d23f0e9cae3878431ca1f78dff7238 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 143 | 77 | 4 | 8f82b3c3331f20c6ded36dbfb9a48dbd9f099f93 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 143 | 77 | 4 | 52832321cc848739ff6483f467d57c50c8b7395c | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 157 | 77 | 4 | d2cb261a9ee2c90e2e0fc656bd6413fbccb465fc | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 157 | 77 | 4 | 350069e4d2dbddc82e813e2a2cc43032daa23605 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 157 | 77 | 4 | b527e88382c8d21188a0f222b3302523e8816dfc | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.70e-04 | 160 | 77 | 4 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.70e-04 | 160 | 77 | 4 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | normal_Lung-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 1.74e-04 | 161 | 77 | 4 | 283012858e575c70d09950de53da041509f59bfa | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-04 | 162 | 77 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 164 | 77 | 4 | f9a2cc12179d5621c9174ec01d7418a71edd28d1 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 1.92e-04 | 165 | 77 | 4 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | Influenza_Severe-pDC|World / Disease group and Cell class | 1.96e-04 | 166 | 77 | 4 | bd25ce4c03c3d6cd9d986b9be1d355da52f0f2d7 | |
| ToppCell | Influenza_Severe-pDC|Influenza_Severe / Disease group and Cell class | 1.96e-04 | 166 | 77 | 4 | b43a5cd4d28118cf6e56a435deb8ea9435608a90 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-pDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.96e-04 | 166 | 77 | 4 | 9fa90d9d484563d44738bb2c6eb0775dffc4d549 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.05e-04 | 168 | 77 | 4 | d03e91f0e0518b33555c0ec98124fc5ed0f11be5 | |
| ToppCell | (3)_DC_plasmacytoid|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.05e-04 | 168 | 77 | 4 | 8a913db9b2a1a4ff96fb139734a3834e6aa263f1 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-pDC|lymph-node_spleen / Manually curated celltypes from each tissue | 2.05e-04 | 168 | 77 | 4 | cfed36fece51871a5abbcde71f6bd5e7212357ff | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-04 | 169 | 77 | 4 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.10e-04 | 169 | 77 | 4 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | severe_influenza-pDC|World / disease group, cell group and cell class (v2) | 2.15e-04 | 170 | 77 | 4 | b9c08af83241666bbdbed9109cadcd088c0f647d | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 2.15e-04 | 170 | 77 | 4 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.20e-04 | 171 | 77 | 4 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.20e-04 | 171 | 77 | 4 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-04 | 171 | 77 | 4 | 10492832db8ebc3cf85503c441f33bd94df9458e | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-04 | 171 | 77 | 4 | 7c0a1b0676f6749ee710c6bdeca6d6f7fac79b69 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-GMP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.20e-04 | 171 | 77 | 4 | 4b8b67c289898ae114a07a2147b5a6f8ec9dd308 | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 2.20e-04 | 171 | 77 | 4 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.25e-04 | 172 | 77 | 4 | 58eaadf12366701103a0d1f133462c9495fedc30 | |
| ToppCell | mild_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 2.25e-04 | 172 | 77 | 4 | dab2f1a05c7df58d9387b13271b3f1f1583f9ac3 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.25e-04 | 172 | 77 | 4 | 4483073469001770015526303772fd54906c5d68 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors|lymph-node_spleen / Manually curated celltypes from each tissue | 2.35e-04 | 174 | 77 | 4 | 029394e107bf7ad58056d2216070aa2e964fff12 | |
| ToppCell | severe_influenza-pDC|severe_influenza / disease group, cell group and cell class (v2) | 2.35e-04 | 174 | 77 | 4 | d8d2ded5812ed3b3db4109585714a6513c13326a | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic|blood / Manually curated celltypes from each tissue | 2.40e-04 | 175 | 77 | 4 | 1c48eec300d5a6d4a810947b995af3b8c0a5a601 | |
| ToppCell | IIF-Myeloid-pDC|IIF / Disease, Lineage and Cell Type | 2.40e-04 | 175 | 77 | 4 | 35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc | |
| ToppCell | mild_COVID-19-pDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.40e-04 | 175 | 77 | 4 | b87f279a7519710146c49d6acccb0adedc195965 | |
| ToppCell | B_cells-pDCs|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.45e-04 | 176 | 77 | 4 | ce757de9e09a225f3f96433f103f43619b0e0dda | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-04 | 177 | 77 | 4 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 2.56e-04 | 178 | 77 | 4 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-04 | 178 | 77 | 4 | 9d575902d3dbe33437c9d4200df093a741269803 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-04 | 178 | 77 | 4 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.61e-04 | 179 | 77 | 4 | 124da6f882968dc0d05f3edd8f3b4d61617cc214 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-pDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-04 | 179 | 77 | 4 | bbd4f8e988ef3f343aaedbc992b70f2bb6aff5f6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.61e-04 | 179 | 77 | 4 | edc5ef693dc4e7ea70717b77fb908fc784dce3a2 | |
| ToppCell | normal_Lung-B_lymphocytes|normal_Lung / Location, Cell class and cell subclass | 2.61e-04 | 179 | 77 | 4 | 5b89193486100b6754c1c5eca3105ea955805eae | |
| ToppCell | moderate-Myeloid-pDC|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.67e-04 | 180 | 77 | 4 | a0751ad5e42a21cb107d900abfa9ee967a0069fc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-04 | 180 | 77 | 4 | 5e78b29fa1cbdcf502fee3577e5b45766b90d1dc | |
| ToppCell | moderate-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.67e-04 | 180 | 77 | 4 | 1d8df7df03a71f49d6683554d3c948ce90dda42e | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 2.73e-04 | 181 | 77 | 4 | 66d890a105f955dca91d6e5e6c730d1a68ee9233 | |
| ToppCell | Healthy/Control-pDC|World / Disease group and Cell class | 2.78e-04 | 182 | 77 | 4 | 97e0eee10905f2cf2bebb09e474629fc224f4397 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.78e-04 | 182 | 77 | 4 | 9bbe8062aa562dc3b9c299581faf6ebbcb72a9f7 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.78e-04 | 182 | 77 | 4 | 4602a98df7045e2c70b7560abfba9b444fbd5d30 | |
| ToppCell | HSPCs-Ery/Mk_prog.|HSPCs / Lineage and Cell class | 2.84e-04 | 183 | 77 | 4 | 59cfb02143b6b54dfca7560562e064948f0340ca | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.84e-04 | 183 | 77 | 4 | 3b123571e10c132227aff65648b4b3c6acb4bd00 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.84e-04 | 183 | 77 | 4 | 1645d4a55cd8c22d6eb47fc5c6b1e576c454f111 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.84e-04 | 183 | 77 | 4 | df6fd0927b6e4cf9a1583969a68096e4bccfbace | |
| ToppCell | (7)_DC_plasmacytoid|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.84e-04 | 183 | 77 | 4 | 2c6475c935b5a90931be6b3c53f1f707cfcd11f4 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.84e-04 | 183 | 77 | 4 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-04 | 183 | 77 | 4 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 184 | 77 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|World / Lineage, cell class and subclass | 2.90e-04 | 184 | 77 | 4 | 11619778bc773ecd1a9867330be04deaf324f31e | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.90e-04 | 184 | 77 | 4 | a809b0fa52df8a159f60f87eefcef61220af5e34 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 184 | 77 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.90e-04 | 184 | 77 | 4 | 34e316ad8e7b8667cd8ad61397281802a252744f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 184 | 77 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | URO-Myeloid-pDC|URO / Disease, Lineage and Cell Type | 2.90e-04 | 184 | 77 | 4 | 0edb5dd003c2bca0b9e3ec18d03610d68bd52538 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 2.90e-04 | 184 | 77 | 4 | 2817d530863e85dfdcd143b7a3dc5fc58a9cd98b | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.96e-04 | 185 | 77 | 4 | cc5152d3055375172bdf84f442b233c8fbd422b3 | |
| ToppCell | Leuk-UTI-Other-RBC|Leuk-UTI / Disease, Lineage and Cell Type | 2.96e-04 | 185 | 77 | 4 | 5b5dd856d6efc0539d92533cff134bbc3f98be45 | |
| ToppCell | (7)_MNP-(7)_DC_plasmacytoid|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.96e-04 | 185 | 77 | 4 | 9f67f652488e17075a372e2a2e1100f6d0af6d7d | |
| ToppCell | Bac-SEP-Myeloid-pDC|Bac-SEP / Disease, Lineage and Cell Type | 2.96e-04 | 185 | 77 | 4 | 3de50b2042f22b0fb62ff12c76d85cc67649a0bd | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.96e-04 | 185 | 77 | 4 | f4588468e8654363f48adbe427dff10f16f1c7fe | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.96e-04 | 185 | 77 | 4 | 3cb816fc9541c04b4436e21d984216cfbbacff98 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.96e-04 | 185 | 77 | 4 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | HSPCs-Eo/Baso_prog.|HSPCs / Lineage and Cell class | 2.96e-04 | 185 | 77 | 4 | 1ae29c0077bfc57e8896e59a21f20af43e7ff5b7 | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.96e-04 | 185 | 77 | 4 | 3091870a5bf8ecb963e560b47c8502bae367416c | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 2.96e-04 | 185 | 77 | 4 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | Leuk-UTI-Other|Leuk-UTI / Disease, Lineage and Cell Type | 2.96e-04 | 185 | 77 | 4 | 895e8087e97ac0eab3446385e6e0dd24bea7f42c | |
| ToppCell | ICU-NoSEP-Myeloid-pDC|ICU-NoSEP / Disease, Lineage and Cell Type | 2.96e-04 | 185 | 77 | 4 | 7564a47df4a4e3af30d40aa0f48bd9d9c82358ae | |
| ToppCell | HSPCs-Eo/Baso_prog.|World / Lineage and Cell class | 2.96e-04 | 185 | 77 | 4 | b40ea11f5e536438b400ca5fddfd4559789036bd | |
| ToppCell | BAL-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.96e-04 | 185 | 77 | 4 | c2e70405969616c28fb6379ee318e17bbcef7b49 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.02e-04 | 186 | 77 | 4 | 31df1eafa3010bc1be6fc4d4689f1393d69b6b13 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.02e-04 | 186 | 77 | 4 | a07694caf7fede06a47636725bcc7f09909cdf07 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.02e-04 | 186 | 77 | 4 | eaa431ccd4cdd36fe06a44987603ec9979025aa8 | |
| ToppCell | Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 3.02e-04 | 186 | 77 | 4 | 330a4f669adea91ff9f2dff2de2210f5e3401e19 | |
| ToppCell | Mild-Lymphoid-pDC|Mild / Condition, Lineage, Cell class and cell subclass | 3.02e-04 | 186 | 77 | 4 | 7fa82972c726025d6402e5eb7bf0db3b699eba4c | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.02e-04 | 186 | 77 | 4 | b95be984e308d4f9061274a35995ec558d434e74 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.02e-04 | 186 | 77 | 4 | 8f7949740286f64e034d1eb533ebc2c6f71ae966 | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.02e-04 | 186 | 77 | 4 | b031f4e6867b6200b85f43276a34749bf5f4603f | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.02e-04 | 186 | 77 | 4 | 95c7318e521fb6aa02e244b1e81e6b2a62107756 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.02e-04 | 186 | 77 | 4 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| Disease | dentatorubral-pallidoluysian atrophy (implicated_via_orthology) | 5.87e-06 | 2 | 72 | 2 | DOID:0060162 (implicated_via_orthology) | |
| Disease | B Virus Infection | 1.76e-05 | 3 | 72 | 2 | C0037140 | |
| Disease | Postherpetic neuralgia | 1.76e-05 | 3 | 72 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 1.76e-05 | 3 | 72 | 2 | C0019372 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.61e-04 | 10 | 72 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.61e-04 | 10 | 72 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.81e-04 | 12 | 72 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 5.24e-04 | 14 | 72 | 2 | DOID:3753 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 5.85e-04 | 156 | 72 | 4 | DOID:10283 (is_marker_for) | |
| Disease | cerebellum white matter volume change measurement | 6.89e-04 | 16 | 72 | 2 | EFO_0021498 | |
| Disease | Drug-induced agranulocytosis | 6.89e-04 | 16 | 72 | 2 | HP_0012235 | |
| Disease | cortical surface area measurement | 1.53e-03 | 1345 | 72 | 10 | EFO_0010736 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement | 2.28e-03 | 29 | 72 | 2 | EFO_0004735, EFO_0004736 | |
| Disease | resistin measurement | 2.28e-03 | 29 | 72 | 2 | EFO_0004819 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ENGSHSFMHSMDPQL | 36 | Q6ZS02 | |
| SAPMSAAHQLQAMHA | 1131 | P54259 | |
| KHMNSSEQAHTATML | 626 | O95490 | |
| HMAMSHKINSDVQPF | 286 | Q86YH6 | |
| HLQGKHNSAPMFMLD | 71 | P18075 | |
| NLPMHAVIMEKSNDH | 1526 | Q9UKL3 | |
| FMSRVALQAEKMNHH | 76 | Q9H0N5 | |
| FEAASMMRQVSHKHI | 636 | P23458 | |
| NDNIMLTKSGHMFHI | 1036 | O75747 | |
| AHTFFVGNPEHMEMQ | 166 | Q32P28 | |
| AAHTFFVANPMHLQM | 176 | Q8IVL6 | |
| FHMQQQAHLKMSSPQ | 866 | Q92585 | |
| QNDAHLHSFSMMPSS | 366 | Q9BYH8 | |
| TSSQAQFHLPMDMVH | 1351 | Q86VF7 | |
| MDMVHLVHAKNAQAL | 1361 | Q86VF7 | |
| TFVNMKAHGNTALHM | 236 | Q8NI38 | |
| SIMHMVANCPHKNVA | 156 | Q6ZN17 | |
| NLQNNPGAMEHFHMK | 81 | P51572 | |
| VHNVSVMHKSLDNMP | 341 | Q7Z6M2 | |
| HAEVFQTCSKVMMHI | 121 | Q96DC8 | |
| AEKHVHNFMMDTQLT | 551 | Q9UGI6 | |
| QPTSHHSPMQDKMVS | 261 | Q8NG81 | |
| DMEGMLQHFQKVIPH | 371 | O60447 | |
| IASMHSQQIRKMEHA | 191 | Q8TDV5 | |
| KMLSPNFDAHHTAML | 256 | O95948 | |
| KMISNPTNFNHVAHM | 1581 | Q9Y5S2 | |
| AHTFFVANPEHMEMQ | 171 | Q8IVL5 | |
| SPHHSPQMMEDFVEK | 521 | P22557 | |
| GMNHDQHLMKCSPAQ | 111 | P30307 | |
| LHQLAMQQSHFPMTH | 246 | Q15366 | |
| NMKIHSVDQGAEHML | 96 | Q9UII4 | |
| SKFPPQNDHNHMCME | 146 | Q9ULV1 | |
| PMLAKQQMHIDSHEA | 1616 | P42858 | |
| PNMTAKCNKTHSFMH | 211 | P26951 | |
| QASSHHLFVQMKSLM | 196 | Q8N1I0 | |
| RMLNEFPHAIAMQHA | 1351 | Q8N1I0 | |
| FNHMNLAEKSTVHMR | 381 | P86791 | |
| MAHSKQPSHFQSLML | 1 | Q58HT5 | |
| FNHMNLAEKSTVHMR | 381 | P86790 | |
| AHIMNSTCAAMPKLH | 491 | O43303 | |
| TKENSANCPMMHQEH | 671 | Q96P31 | |
| HMATTAFMQPDHAGI | 681 | Q6MZM0 | |
| NFSTNMEIPRAMFHH | 316 | Q9P267 | |
| FHSNVHSQVPMMNVS | 381 | Q9P267 | |
| MFHSSAMVNSHRKPM | 1 | Q6P179 | |
| QKTPRDVVMMENFHH | 721 | Q9NV70 | |
| TTFEHAHNMRVMKFS | 486 | P13639 | |
| FMSEAVIMKNLDHPH | 471 | Q14289 | |
| QMTIENMNHLKFIPH | 421 | Q9BTE3 | |
| NNCHERAFVFMHKMP | 96 | Q9HCS7 | |
| PFMLVDMKDSFHHNV | 36 | Q9BRQ8 | |
| SKLHSSPQMAAQHNM | 376 | Q9Y6U3 | |
| LMFSHPAFNQLCEHM | 206 | Q9NYY8 | |
| MAHHLPAAMESHQDF | 1 | Q96QH2 | |
| MSRAFEETKHFPMNH | 1241 | Q8TCU6 | |
| LNTLFMAMEHHPMTE | 756 | Q15858 | |
| MSAAHQLQAMHAQSA | 1511 | Q9P2R6 | |
| QLDVSHTLQKHMMFI | 146 | Q86UD7 | |
| MFKQIHMVHKPDDDT | 101 | O94875 | |
| HVPMMHQKEQFAFGV | 236 | Q86WD7 | |
| MAFPRNSIMHLNHTA | 501 | O95628 | |
| PLPSQQMFEHMQKRH | 136 | Q96JJ7 | |
| TQTAMDQLHMHFTQA | 266 | Q96JG6 | |
| KVFNEHPFLMTHMIT | 121 | Q147U1 | |
| AMTMQFISHRFPEDH | 36 | Q92963 | |
| VMKHGFIADNQMNHA | 621 | Q15022 | |
| KEKAFLPMVSHTFHM | 61 | Q86VQ3 | |
| EVHQTHIKMFHLPMS | 111 | A2RTY3 | |
| NVSKMMQAHINPVFD | 781 | P55017 | |
| NTLFMAMEHHPMTPQ | 766 | Q9UQD0 | |
| HVRLPNEAHNCMDKM | 111 | Q9NRE2 | |
| QLDVSHTLQKHMMFI | 146 | Q2M2D7 | |
| NKAFVNHMMSSHSNH | 651 | Q8ND82 | |
| NHMMSSHSNHPGKRF | 656 | Q8ND82 | |
| TMECLQEFPEHHKMI | 6 | P52739 | |
| DTQAMKEMHFHPKAL | 1091 | P11498 | |
| MAFHEMQAHKNALGT | 1 | Q9NQA3 | |
| DSNHHMPKSSLAKHM | 61 | Q6IEG0 | |
| FTHNMFPVPNNLHMA | 276 | A8MT65 | |
| NLNRHSMVHMQEKSF | 301 | Q2VY69 | |
| KANVHIPNDMMNHVL | 4541 | P20929 |